Tablet formulation for CGRP-active compounds

Colloidal Silica (Cob-O-Sil) Cosieve Microcrystalne Celluloe(Acl) Milled dispersion Screen (optional) Mannili NaCl Powder Crocarmellse Sodum Blend/Lubdcate Coseved Cob-O-Sil/Avicel Sodium Stearyl Fumarate Compress to Tablet R"R The present invention is directed to compositions comprising an ext...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IKEDA, Craig B, XU, Wei, ALLAIN, Leonardo Resende, LUPTON, Lisa, NOFSINGER, Rebecca, EICKHOFF, W. Mark, FLANAGAN Jr., Francis J, XI, Hanmi, MAROTA, Melanie, PATEL, Paresh B, JOHNSON, Mary Ann, BROWN, Chad D
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IKEDA, Craig B
XU, Wei
ALLAIN, Leonardo Resende
LUPTON, Lisa
NOFSINGER, Rebecca
EICKHOFF, W. Mark
FLANAGAN Jr., Francis J
XI, Hanmi
MAROTA, Melanie
PATEL, Paresh B
JOHNSON, Mary Ann
BROWN, Chad D
description Colloidal Silica (Cob-O-Sil) Cosieve Microcrystalne Celluloe(Acl) Milled dispersion Screen (optional) Mannili NaCl Powder Crocarmellse Sodum Blend/Lubdcate Coseved Cob-O-Sil/Avicel Sodium Stearyl Fumarate Compress to Tablet R"R The present invention is directed to compositions comprising an extmdate or solid solution of a compound, or a salt thereof, of Formula I (API): Formula I, wherein "Ra" is independently H or -F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021245229A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021245229A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021245229A13</originalsourceid><addsrcrecordid>eNrjZNAJSUzKSS1RSMsvyi3NSSzJzM8DsRWc3YMCdBOTSzLLUhWS83ML8kvzUop5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8Y6iRgZGhkYmpkZGlo6ExcaoAHi8qXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Tablet formulation for CGRP-active compounds</title><source>esp@cenet</source><creator>IKEDA, Craig B ; XU, Wei ; ALLAIN, Leonardo Resende ; LUPTON, Lisa ; NOFSINGER, Rebecca ; EICKHOFF, W. Mark ; FLANAGAN Jr., Francis J ; XI, Hanmi ; MAROTA, Melanie ; PATEL, Paresh B ; JOHNSON, Mary Ann ; BROWN, Chad D</creator><creatorcontrib>IKEDA, Craig B ; XU, Wei ; ALLAIN, Leonardo Resende ; LUPTON, Lisa ; NOFSINGER, Rebecca ; EICKHOFF, W. Mark ; FLANAGAN Jr., Francis J ; XI, Hanmi ; MAROTA, Melanie ; PATEL, Paresh B ; JOHNSON, Mary Ann ; BROWN, Chad D</creatorcontrib><description>Colloidal Silica (Cob-O-Sil) Cosieve Microcrystalne Celluloe(Acl) Milled dispersion Screen (optional) Mannili NaCl Powder Crocarmellse Sodum Blend/Lubdcate Coseved Cob-O-Sil/Avicel Sodium Stearyl Fumarate Compress to Tablet R"R The present invention is directed to compositions comprising an extmdate or solid solution of a compound, or a salt thereof, of Formula I (API): Formula I, wherein "Ra" is independently H or -F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211104&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021245229A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211104&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021245229A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IKEDA, Craig B</creatorcontrib><creatorcontrib>XU, Wei</creatorcontrib><creatorcontrib>ALLAIN, Leonardo Resende</creatorcontrib><creatorcontrib>LUPTON, Lisa</creatorcontrib><creatorcontrib>NOFSINGER, Rebecca</creatorcontrib><creatorcontrib>EICKHOFF, W. Mark</creatorcontrib><creatorcontrib>FLANAGAN Jr., Francis J</creatorcontrib><creatorcontrib>XI, Hanmi</creatorcontrib><creatorcontrib>MAROTA, Melanie</creatorcontrib><creatorcontrib>PATEL, Paresh B</creatorcontrib><creatorcontrib>JOHNSON, Mary Ann</creatorcontrib><creatorcontrib>BROWN, Chad D</creatorcontrib><title>Tablet formulation for CGRP-active compounds</title><description>Colloidal Silica (Cob-O-Sil) Cosieve Microcrystalne Celluloe(Acl) Milled dispersion Screen (optional) Mannili NaCl Powder Crocarmellse Sodum Blend/Lubdcate Coseved Cob-O-Sil/Avicel Sodium Stearyl Fumarate Compress to Tablet R"R The present invention is directed to compositions comprising an extmdate or solid solution of a compound, or a salt thereof, of Formula I (API): Formula I, wherein "Ra" is independently H or -F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAJSUzKSS1RSMsvyi3NSSzJzM8DsRWc3YMCdBOTSzLLUhWS83ML8kvzUop5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8Y6iRgZGhkYmpkZGlo6ExcaoAHi8qXQ</recordid><startdate>20211104</startdate><enddate>20211104</enddate><creator>IKEDA, Craig B</creator><creator>XU, Wei</creator><creator>ALLAIN, Leonardo Resende</creator><creator>LUPTON, Lisa</creator><creator>NOFSINGER, Rebecca</creator><creator>EICKHOFF, W. Mark</creator><creator>FLANAGAN Jr., Francis J</creator><creator>XI, Hanmi</creator><creator>MAROTA, Melanie</creator><creator>PATEL, Paresh B</creator><creator>JOHNSON, Mary Ann</creator><creator>BROWN, Chad D</creator><scope>EVB</scope></search><sort><creationdate>20211104</creationdate><title>Tablet formulation for CGRP-active compounds</title><author>IKEDA, Craig B ; XU, Wei ; ALLAIN, Leonardo Resende ; LUPTON, Lisa ; NOFSINGER, Rebecca ; EICKHOFF, W. Mark ; FLANAGAN Jr., Francis J ; XI, Hanmi ; MAROTA, Melanie ; PATEL, Paresh B ; JOHNSON, Mary Ann ; BROWN, Chad D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021245229A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>IKEDA, Craig B</creatorcontrib><creatorcontrib>XU, Wei</creatorcontrib><creatorcontrib>ALLAIN, Leonardo Resende</creatorcontrib><creatorcontrib>LUPTON, Lisa</creatorcontrib><creatorcontrib>NOFSINGER, Rebecca</creatorcontrib><creatorcontrib>EICKHOFF, W. Mark</creatorcontrib><creatorcontrib>FLANAGAN Jr., Francis J</creatorcontrib><creatorcontrib>XI, Hanmi</creatorcontrib><creatorcontrib>MAROTA, Melanie</creatorcontrib><creatorcontrib>PATEL, Paresh B</creatorcontrib><creatorcontrib>JOHNSON, Mary Ann</creatorcontrib><creatorcontrib>BROWN, Chad D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IKEDA, Craig B</au><au>XU, Wei</au><au>ALLAIN, Leonardo Resende</au><au>LUPTON, Lisa</au><au>NOFSINGER, Rebecca</au><au>EICKHOFF, W. Mark</au><au>FLANAGAN Jr., Francis J</au><au>XI, Hanmi</au><au>MAROTA, Melanie</au><au>PATEL, Paresh B</au><au>JOHNSON, Mary Ann</au><au>BROWN, Chad D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Tablet formulation for CGRP-active compounds</title><date>2021-11-04</date><risdate>2021</risdate><abstract>Colloidal Silica (Cob-O-Sil) Cosieve Microcrystalne Celluloe(Acl) Milled dispersion Screen (optional) Mannili NaCl Powder Crocarmellse Sodum Blend/Lubdcate Coseved Cob-O-Sil/Avicel Sodium Stearyl Fumarate Compress to Tablet R"R The present invention is directed to compositions comprising an extmdate or solid solution of a compound, or a salt thereof, of Formula I (API): Formula I, wherein "Ra" is independently H or -F, in a water-soluble polymer matrix which further comprises a disintegration system allowing a tablet made therefrom to rapidly disintegrate in the environment in which the API is to be released.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2021245229A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Tablet formulation for CGRP-active compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A29%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IKEDA,%20Craig%20B&rft.date=2021-11-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021245229A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true